Bolt Biotherapeutics (BOLT) Live Share Price, Invest From India

Bolt Biotherapeutics Stock Performance

as on September 5, 2026 at 2:16 pm IST

Day's Low
Day's High
$3.85
Day's Price Range
$4.00
$3.90
1.28%
Downside
2.56%
Upside
52 Week's Low
52 Week's High
$3.13
52-Week Price Range
$7.20
$3.90
19.74%
Downside
84.61%
Upside

Bolt Biotherapeutics share price movements today

Previous Close: $3.90
Open: $3.90
Volume: 69.7K
Market Cap: $7.8M
Day's Low - High: $3.85 - $4.00
52 Week Low - High: $3.13 - $7.20

Bolt Biotherapeutics Historical Returns

1 Month Return: -1.39 %
3 Month Return: -18.17 %
1 Year Return: -19.52 %
3 Year Return: -81.97 %
5 Year Return: -98.95 %

Bolt Biotherapeutics Stock Fundamentals & Key Indicators

Check Bolt Biotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.8M

EPS (TTM)

-26.285

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-27.6M

Revenue (TTM)

4.7M

Profit Margin

0.00%

Return On Equity TTM

-111.65%

Bolt Biotherapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bolt Biotherapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Bolt Biotherapeutics	BUY	$7.8M	-98.95%	NA	0.00%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$141.1B	181.73%	32.21	86.04%	NA
Moderna	BUY	$60.2B	-64.27%	-18.66	-12.57%	NA
Regeneron	BUY	$84.8B	24.12%	20.14	84.86%	0.44%

Stock Returns calculator for Bolt Biotherapeutics Stock including INR - Dollar returns

The Bolt Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Bolt Biotherapeutics investment value today

Current value as on today

₹86,327

Returns

-₹13,673

(-13.67%)

Returns from Bolt Biotherapeutics Stock

-₹19,421 (-19.42%)

Dollar Impact

₹5,749 (+5.75%)

Analyst Recommendation on Bolt Biotherapeutics Stock

Based on 1 analysts

BUY

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Bolt Biotherapeutics. Average target price of $29

Bolt Biotherapeutics Share Price Target

Get share price movements and forecasts by analysts on Bolt Biotherapeutics.

What analysts predicted

86.55%UPSIDE

Target Price

$29

Current Price

$3.9

Analyzed by

1 Analysts

Target

$29.00

Bolt Biotherapeutics target price $29, a slight upside of 86.55% compared to current price of $3.9. According to 1 analysts rating.

Indian Investors' Interest in Bolt Biotherapeutics Stock

Search interest for Bolt Biotherapeutics Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 6, 2026 to September 5, 2026

Change:26% versus previous 30 day period

Bolt Biotherapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	5	1	1	24	1	1	2	2	0	0
Gross Profit	4	-14	-12	0	1	1	2	2	0	0
Operating Income	-17	-22	-16	-15	-12	-9	-7	-5	-7	-8
EBITDA	-10	-18	-14	-15	-10	-8	-6	-6	-7	-7
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-10	-21	-15	-15	-11	-8	-7	-6	-7	-7
Income Tax Expense	0	-	-	-	-	-	-	-	-	-
Net Income	-10	-21	-15	-15	-11	-8	-7	-6	-7	-7
Net Profit Margin	-204.99%	-1662.35%	-1330.06%	-66.15%	-903.44%	-474.56%	-329.37%	-265.24%	-27861.54%	-154400.00%

Bolt Biotherapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	0	0	1	5	7	7	7
Gross Profit	0	0	-40	-74	-67	-53	7	6
Operating Income	-11	-30	-49	-92	-90	-76	-73	-34
EBITDA	-11	-30	-48	-97	-86	-67	-66	-31
Interest Expense	-	-	-	5	2	-	-	-
Depreciation	0	0	0	1	1	1	1	1
Income Before Tax	-11	-30	-60	-98	-88	-69	-63	-33
Income Tax Expense	0	0	11	5	-2	1	-	-
Net Income	-11	-30	-60	-98	-88	-69	-63	-33
Net Profit Margin	0.00%	-14180.00%	-26289.18%	-7824.68%	-1537.76%	-878.58%	-820.78%	-433.74%

Bolt Biotherapeutics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-21	-15	-15	-11	-8	-7	-6	-7	-7
Operating Cash Flow	-16	-13	-14	-13	-9	-9	-7	-8	-6
Investing Cash Flow	18	17	12	14	10	17	1	7	7
Financing Cash Flow	0	-	0	-	0	-	0	0	0
Change in Cash	1	3	-2	1	1	8	-6	0	1

Bolt Biotherapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-30	-60	-98	-88	-69	-63	-33
Operating Cash Flow	-26	-47	-57	-76	-69	-61	-39
Investing Cash Flow	0	-20	-232	57	71	57	44
Financing Cash Flow	48	39	311	0	0	0	0
Change in Cash	21	-28	21	-18	1	-3	4

Mutual Funds that own Bolt Biotherapeutics Stock

Check out the Mutual Funds with significant holdings in Bolt Biotherapeutics.

Funds	Holdings	Shares Held
Fidelity Commonwealth Trust II	2.631667%	50695
Fidelity Concord Street Trust	0.821555%	15826
VANGUARD INDEX FUNDS	0.366497%	7060
Victory Portfolios III	0.140161%	2700

Global Institutional Holdings in Bolt Biotherapeutics

Funds	Holdings
Vanguard	0.37%

Insights on Bolt Biotherapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 479.0% return, outperforming this stock by 503.9%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 33.1% return, outperforming this stock by 115.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -6.63M → -7.72M (in $), with an average decrease of 7.9% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 2.5M → 5.0K (in $), with an average decrease of 89.9% per quarter
NEGATIVE IMPACT
Price Dip
In the last 3 years, BOLT stock has moved down by -82.4%

About Bolt Biotherapeutics

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company's pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors; CEA ISAC, a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5 for the treatment of solid tumors, including colorectal, non-small cell lung, pancreatic, and breast; and PD-L1 ISAC, a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker to target both tumor and immune cells for the treatment of tumor regression and immunological memory. The company has collaboration agreements with Toray Industries, Genmab A/S, and Innovent Biologics, Inc.; and a license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Organisation	Bolt Biotherapeutics
Headquarters	900 Chesapeake Drive, Redwood City, CA, United States, 94063
Industry	Biotechnology
CEO	Mr. William P. Quinn
E-voting on shares	Click here to vote

Key Management of Bolt Biotherapeutics

Name	Title
Mr. William P. Quinn	CEO, CFO, President, Secretary & Director
Mr. Grant Yonehiro C.F.A., M.B.A.	COO & Chief Business Officer
Ms. Sarah Nemec	Senior VP of Finance & Principal Accounting Officer
Dr. Michael N. Alonso Ph.D.	Senior Vice President of Research
Mr. Justin Kenkel	Senior Principal Scientist

FAQs

What is Bolt Biotherapeutics share price today?

Bolt Biotherapeutics share price today is $3.90 as on September 5, 2026 at 8:46 am IST at the close of the market. Bolt Biotherapeutics share today touched a day high of $4.00 and a low of $3.85.

What is the 52 week high and 52 week low for Bolt Biotherapeutics share?

Bolt Biotherapeutics share touched a 52 week high of $7.20 on January 16, 2026 and a 52 week low of $3.13 on August 12, 2026. Bolt Biotherapeutics stock price today i.e. September 5, 2026 at 8:46 am IST is closed at $3.90,which is 45.83% down from its 52 week high and 24.60% up from its 52 week low.

What is Bolt Biotherapeutics's market capitalisation today?

Bolt Biotherapeutics market capitalisation is $0.00T as on September 5, 2026 at 8:46 am IST.

How to invest in Bolt Biotherapeutics Stock (BOLT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Bolt Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bolt Biotherapeutics Shares that will get you 0.3846 shares as per Bolt Biotherapeutics share price of $3.90 per share as on September 5, 2026 at 8:46 am IST.

What is the minimum amount required to buy Bolt Biotherapeutics Stock (BOLT) from India?

Indian investors can start investing in Bolt Biotherapeutics (BOLT) shares with as little as ₹94.485 or $1 (as of September 5, 2026 at 9:49 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹944.85 in Bolt Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on September 5, 2026 at 9:49 am IST). Based on Bolt Biotherapeutics share’s latest price of $3.90 as on September 5, 2026 at 8:46 am IST, you will get 2.5641 shares of Bolt Biotherapeutics. Learn more about fractional shares .

What are the returns that Bolt Biotherapeutics has given to Indian investors in the last 5 years?

Bolt Biotherapeutics stock has given -98.95% share price returns and 29.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?